石四药集团(02005)：甲氧氯普胺及盐酸甲氧氯普胺获国家药监局批准登记成为在上市制剂使用的原料药

Group 1 - The company Shijiazhuang Four Medicines Group (stock code: 02005) announced that its Metoclopramide and Hydrochloride Metoclopramide have been approved by the National Medical Products Administration of China for registration as active pharmaceutical ingredients for use in marketed formulations [1] - Both active pharmaceutical ingredients are classified as dopamine receptor D2 antagonists and also exhibit 5-hydroxytryptamine 4 (5-HT4) receptor agonist effects, promoting gastrointestinal motility [1] - The primary applications of these drugs include antiemetic treatment and management of nausea, belching, abdominal distension, and gastroesophageal reflux disease [1]